APA (7th ed.) Citation

Yao, J., Geng, Y., Xu, J., Zou, B., & Teng, F. The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLC. BMC.

Chicago Style (17th ed.) Citation

Yao, Jinquan, Yuxin Geng, Junhao Xu, Bingwen Zou, and Feifei Teng. The Impact of EGFR Mutation and PD-L1 Status on the Efficacy of Postoperative Radiotherapy in Stage III-pN2 NSCLC. BMC.

MLA (9th ed.) Citation

Yao, Jinquan, et al. The Impact of EGFR Mutation and PD-L1 Status on the Efficacy of Postoperative Radiotherapy in Stage III-pN2 NSCLC. BMC.